Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BMJ Publishing Group
2014
|
| _version_ | 1797052740979916800 |
|---|---|
| author | Kitley, J Leite, M Elsone, L Jacob, A Palace, J |
| author_facet | Kitley, J Leite, M Elsone, L Jacob, A Palace, J |
| author_sort | Kitley, J |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T18:34:54Z |
| format | Journal article |
| id | oxford-uuid:0ae3a503-6efa-43d3-95be-5a1c8e4c12ee |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:34:54Z |
| publishDate | 2014 |
| publisher | BMJ Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:0ae3a503-6efa-43d3-95be-5a1c8e4c12ee2022-03-26T09:26:28ZTime to next relapse as a primary endpoint in neuromyelitis optica clinical trials.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0ae3a503-6efa-43d3-95be-5a1c8e4c12eeEnglishSymplectic Elements at OxfordBMJ Publishing Group2014Kitley, JLeite, MElsone, LJacob, APalace, J |
| spellingShingle | Kitley, J Leite, M Elsone, L Jacob, A Palace, J Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials. |
| title | Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials. |
| title_full | Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials. |
| title_fullStr | Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials. |
| title_full_unstemmed | Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials. |
| title_short | Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials. |
| title_sort | time to next relapse as a primary endpoint in neuromyelitis optica clinical trials |
| work_keys_str_mv | AT kitleyj timetonextrelapseasaprimaryendpointinneuromyelitisopticaclinicaltrials AT leitem timetonextrelapseasaprimaryendpointinneuromyelitisopticaclinicaltrials AT elsonel timetonextrelapseasaprimaryendpointinneuromyelitisopticaclinicaltrials AT jacoba timetonextrelapseasaprimaryendpointinneuromyelitisopticaclinicaltrials AT palacej timetonextrelapseasaprimaryendpointinneuromyelitisopticaclinicaltrials |